Clinical Trial, Phase IIIHumanClinical Trial, Phase III
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
The New England journal of medicine, 2025 Jul 3. Aronne LJ, Horn DB, le Roux CW and 9 others.
Study type
Clinical trial · Clinical Trial, Phase III
Subjects
Human participants (PubMed MeSH: Humans)
Journal
The New England journal of medicine
Published
2025 Jul 3
PubMed
Indexed under
MeSH terms assigned by the National Library of Medicine.
AdultAgedFemaleHumansMaleMiddle AgedAnti-Obesity AgentsInjections, SubcutaneousMaximum Tolerated DoseObesityTirzepatideWaist Circumference
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page